New Cryo-TEM System Provides Scientists a Closer Look at Life HILLSBORO, Ore. -- The Institute Pasteur officially unveiled its new Thermo Scientific Krios Cryo-TEM electron microscope at an event in Paris, France today. The availability of one of the most powerful commercially available microscopes in the world in the center of Paris will allow structural biologists at the Institut Pasteur to [...]

Sydney, Australia - Crystallographers at the University of Melbourne received a boost following the installation of a state-of-the-art small molecule X-ray diffraction (XRD) machine. The XtaLAB Synergy-S from Rigaku Oxford Diffraction (ROD) is a class-leading instrument that marries cutting edge technologies that will enable their researchers to generate world-class data. The system was installed by AXT Pty. Ltd. [...]

SHANGHAI -- OrigiMed announces an agreement with Illumina in Shanghai, China. It will develop and promote its advanced molecular clinical tumor applications to the public based on the Next Generation Sequencing (NGS) technology of Illumina. This marks further cooperation between Illumina and Chinese enterprises. It also signals that genomics technology will play an increasingly important future role in the [...]

Sequences and Assay Data Captured in a Single Platform CDD Vault recently updated the text readout size (now 65,000 characters) for both the Synonyms and Protocol Readouts to lay the groundwork for assisting researchers using biologics instead of traditional small molecules. CDD Vault has a powerful storage and query engine to store and mine your [...]

Ness Ziona, Israel – Buckwheat researchers from Japan now have access to the most accurate genome available, thanks to NRGene. The project was done with Dr. Yasuo Yasui, a renowned buckwheat scientist, in cooperation with GeneBay, NRGene’s partner in Japan. The results were presented yesterday at the annual meeting of the Society for Molecular Biology [...]

Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform   Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) [...]

Porvair is a leading developer and manufacturer of sintered porous materials that offer optimum solutions in a wide range of applications. Developed for the Bioscience market - BioVyon™ is a high-performance porous polymeric material manufactured to the highest cleanliness standards. This unique material, produced from high-density polyethylene resin using a proprietary process that can be [...]

Public-private alliances will create world-leading genomics campus and accelerate commercialization Manchester, United Kingdom, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K., for innovation, life sciences, translational science and molecular diagnostics. QIAGEN is working with Health [...]

Shimadzu Corporation (hereinafter “Shimadzu") has signed an agreement to acquire all shares of infraserv Vakuumservice GmbH (hereinafter "IVG"), which is involved in servicing turbomolecular pumps in Europe. After completion of the required acquisition process, IVG will be our wholly owned subsidiary in July. Background and Purpose of Acquisition In the semiconductor market expected to further [...]

FORT COLLINS, Colo. -- KromaTiD, Inc. announced today that it has joined the National Institute of Standards and Technology Genome Editing Consortium, a newly launched public/private partnership (https://www.nist.gov/programs-projects/nist-genome-editing-consortium). The Consortium supports the emerging gene editing market and regulatory agency needs for standardized measurements of gene edits, editing by-products and the risks of utilizing genome editing technologies in research, [...]